Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer

Published:2020-05 Issue:5 Volume:109 Page:1512-1520
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Toubat Omar,Atay Scott M.,Kim Anthony W.,Ding Li,Farias Albert J.,Ebner Peggy J.,McFadden P. Michael,David Elizabeth A.

Funder

American College of Surgeons

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference28 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Histologic lung cancer incidence rates and trends vary by race/ethnicity and residential county;Houston;J Thorac Oncol,2018

3. Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology;Ettinger;J Natl Compr Canc Netw,2017

4. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Howington;Chest,2013

5. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N Engl J Med,2004

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Update of Guideline-based Quality Indicators in Lung Cancer;TumorDiagnostik & Therapie;2024-09

2. What alters prognosis in patients who were operated for lung cancer with lymph node metastasis?;ANZ Journal of Surgery;2024-08-28

3. Benefits of adjuvant chemotherapy in elderly patients with stage IB–IIIB non-small cell lung cancer: a propensity-matched analysis;Translational Cancer Research;2024-06

4. Survival difference between patients with single versus multiple metastatic lymph nodes and the role of histology in pathological stage II-N1 non-small cell lung cancer;Acta Chirurgica Belgica;2024-02-28

5. Development and Update of Guideline-based Quality Indicators in Lung Cancer;Pneumologie;2023-12-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3